Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 08, 2024

Plasma Angiogenic Factors as Predictors of the Efficacy of Second-Line Chemotherapy Plus Angiogenesis Inhibitors in Metastatic Colorectal Cancer

Clinical Colorectal Cancer

 

Additional Info

Clinical Colorectal Cancer
Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study
Clin Colorectal Cancer 2024 Jun 01;23(2)147-159.e7, S Yuki, K Yamazaki, Y Sunakawa, H Taniguchi, H Bando, M Shiozawa, T Nishina, H Yasui, A Kanazawa, K Ando, Y Horita, M Goto, N Okano, T Moriwaki, T Satoh, A Tsuji, K Yamashita, C Asano, Y Abe, S Nomura, T Yoshino

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading